219 related articles for article (PubMed ID: 10936477)
1. Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation.
Pearce LA; Hart RG; Halperin JL
Am J Med; 2000 Jul; 109(1):45-51. PubMed ID: 10936477
[TBL] [Abstract][Full Text] [Related]
2. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.
Gage BF; van Walraven C; Pearce L; Hart RG; Koudstaal PJ; Boode BS; Petersen P
Circulation; 2004 Oct; 110(16):2287-92. PubMed ID: 15477396
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.
Hart RG; Pearce LA; McBride R; Rothbart RM; Asinger RW
Stroke; 1999 Jun; 30(6):1223-9. PubMed ID: 10356104
[TBL] [Abstract][Full Text] [Related]
4. Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong.
Siu CW; Lip GY; Lam KF; Tse HF
Heart Rhythm; 2014 Aug; 11(8):1401-8. PubMed ID: 24747420
[TBL] [Abstract][Full Text] [Related]
5. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators.
JAMA; 1998 Apr 22-29; 279(16):1273-7. PubMed ID: 9565007
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of ischemic stroke in middle aged patients with atrial fibrillation. Effect of sinus rhythm maintenance, aspirin, warfarin, and simvastatin].
Kanorskiĭ SG; Shevelev VI; Zafiraki VK; Zingilevskiĭ KB
Kardiologiia; 2007; 47(1):26-30. PubMed ID: 17426677
[TBL] [Abstract][Full Text] [Related]
7. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
[TBL] [Abstract][Full Text] [Related]
8. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation.
Yu HC; Tsai YF; Chen MC; Yeh CH
Int J Stroke; 2012 Feb; 7(2):112-7. PubMed ID: 22103748
[TBL] [Abstract][Full Text] [Related]
9. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
[TBL] [Abstract][Full Text] [Related]
10. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography.
Ann Intern Med; 1998 Apr; 128(8):639-47. PubMed ID: 9537937
[TBL] [Abstract][Full Text] [Related]
11. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
12. Incidence of new thromboembolic stroke in persons 62 years and older with chronic atrial fibrillation treated with warfarin versus aspirin.
Aronow WS; Ahn C; Kronzon I; Gutstein H
J Am Geriatr Soc; 1999 Mar; 47(3):366-8. PubMed ID: 10078902
[TBL] [Abstract][Full Text] [Related]
13. Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Lip GY; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
Stroke; 2016 Oct; 47(10):2462-9. PubMed ID: 27625386
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
15. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
16. [Atrial fibrillation and apoplexy--risks and prevention].
Koefoed BG; Gulløv AL; Petersen P
Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
[TBL] [Abstract][Full Text] [Related]
17. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.
Fang MC; Go AS; Chang Y; Borowsky L; Pomernacki NK; Singer DE;
J Am Coll Cardiol; 2008 Feb; 51(8):810-5. PubMed ID: 18294564
[TBL] [Abstract][Full Text] [Related]
18. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
19. Preventing stroke in patients with atrial fibrillation.
Ezekowitz MD; Levine JA
JAMA; 1999 May; 281(19):1830-5. PubMed ID: 10340371
[TBL] [Abstract][Full Text] [Related]
20. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
